{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:25:45Z","timestamp":1761647145061},"reference-count":27,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1211,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[1998,9]]},"abstract":"<jats:p>Antiphospholipid antibodies associated with the antiphospholipid syndrome (APS) have been shown to bind plasma proteins, particularly beta 2\u2010glycoprotein I (\u03b22\u2010GPI). In this study the incidence of antibodies to solid\u2010phase prothrombin was examined in patients with antiphospholipid syndrome and a variety of other inflammatory disorders.<\/jats:p><jats:p>Significantly elevated levels of IgG anti\u2010prothrombin (anti\u2010PT) antibodies were detected in 63% of patients with APS (<jats:italic>n<\/jats:italic>\u2003=\u200327, median 22 arbitrary units:\u2003AU), 33% with SLE (<jats:italic>n<\/jats:italic>\u2003= 92, median 14\u2003AU), 45% with rheumatoid factor (<jats:italic>n<\/jats:italic>\u2003=\u200322, median 16\u2003AU), 21% with carotid artery stenosis (<jats:italic>n<\/jats:italic>\u2003=\u200321, median 15\u2003AU), 32% with stroke (<jats:italic>n<\/jats:italic>\u2003=\u200338, median 13\u2003AU), 67% of patients with a false positive serology for syphilis (<jats:italic>n<\/jats:italic>\u2003= 21, median 24\u2003AU), 37% with HIV (<jats:italic>n<\/jats:italic>\u2003=\u200330, median 14\u2003AU), 29% with syphilis (<jats:italic>n<\/jats:italic>\u2003=\u200314, median 19\u2003AU) and 3% with infectious mononucleosis (<jats:italic>n<\/jats:italic>\u2003=\u200330, median 9\u2003AU). In addition, a group of lupus anticoagulant (LA) positive patients (<jats:italic>n<\/jats:italic>\u2003=\u200348) was examined for antibodies to prothrombin, \u03b22\u2010GPI and cardiolipin. 10 (21%) patients had raised levels of IgG anti\u2010PT antibodies, 30 (62%) had significantly elevated levels of anti\u2010\u03b22\u2010GPI antibodies and 15 (31%) had elevated levels of anticardiolipin antibodies (ACA). Of the LA\u2010positive patients, 15 (43%) were identified with definite APS, eight (23%) with probable APS, two (6%) with possible APS and 10 (28%) patients had no clinical evidence of APS.<\/jats:p><jats:p>In conclusion, antibodies to prothrombin were found in a variety of inflammatory disorders and were therefore not specific for the APS. However, identification of the plasma proteins recognized by antibodies from patients with APS may provide insight into the pathogenic mechanisms involved in the heterogenous clinical manifestations of the APS.<\/jats:p>","DOI":"10.1046\/j.1365-2141.1998.00876.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:04:10Z","timestamp":1047362650000},"page":"896-902","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Antibodies to prothrombin in antiphospholipid syndrome and inflammatory disorders"],"prefix":"10.1111","volume":"102","author":[{"given":"Jan","family":"Guerin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gertrude","family":"Sweetman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conleth","family":"Feighery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"482","article-title":"Primary antiphospholipid syndrome","volume":"16","author":"Alarc\u00f3n\u2010Segovia D.","year":"1989","journal-title":"Journal of Rheumatology"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1649891"},{"key":"e_1_2_6_4_2","first-page":"1742","article-title":"A \u2018primary\u2019 antiphospholipid syndrome?","volume":"15","author":"Asherson R.A.","year":"1988","journal-title":"Journal of Rheumatology"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/096120339500400208"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1646476"},{"key":"e_1_2_6_7_2","first-page":"1597","article-title":"Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants. On behalf of the Subcommittee on Lupus Anticoagulants\/Antiphospholipid Antibodies of ISTH","volume":"74","author":"Brandt J.T.","year":"1955","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1657678"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1655994"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91374-J"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1997.4601357.x"},{"key":"e_1_2_6_12_2","first-page":"486","article-title":"The anticardiolipin syndrome","volume":"13","author":"Hughes G.R.V.","year":"1986","journal-title":"Journal of Rheumatology"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.46.7.665"},{"key":"e_1_2_6_14_2","unstructured":"Loizou S.A. Walport M.J. Davies K.A.(1996) The antiphospholipid syndrome in infectious diseases.The Antiphospholipid Syndrome(ed. by R. A. Asherson R. Cervesa J. C. Piette and Y. Shoenfeld) pp.267284. CRC Press New York."},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-9-682"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.2.457"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/34.11.1031"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60777-4"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.11.4120"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.10.2618.2618"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1993.tb03220.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1650355"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.10.2878.2878"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1653838"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.11.4173.bloodjournal88114173"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4049\/jimmunol.154.2.954","article-title":"\u2018Anticardiolipin\u2019 autoantibodies recognize beta 2\u2010glycoprotein I in the absence of phospholipid: importance of Ag density and bivalent binding","volume":"154","author":"Roubey R.A.","year":"1995","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_27_2","first-page":"1710","article-title":"Prevalence of anti\u2010\u03b22\u2010glycoprotein I, antiprothrombin antibodies and lupus anticoagulant in patients with systemic lupus erythematosus and a history of thrombosis","volume":"24","author":"Swadzba J.","year":"1997","journal-title":"Journal of Rheumatology"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780251101"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.1998.00876.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.1998.00876.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1365-2141.1998.00876.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.1998.00876.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T22:27:21Z","timestamp":1694039241000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.1998.00876.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["10.1046\/j.1365-2141.1998.00876.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.1998.00876.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9]]},"assertion":[{"value":"2001-12-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}